Why Traditional Thought Leader Mapping Is No Longer Enough In today’s patient-driven healthcare environment, traditional thought leader (TL) mapping methods—focused only on physician credentials, publications, and conference activity—no longer […]
Put the Competition in Check with TRUE Clinical Influencers The Double Attack. A double attack in chess is when you create multiple threats with one move. In today’s challenging HCP
AI-Driven Clinical Mapping: Maximizing Healthcare Engagement Read More »
While artificial intelligence (AI) has undoubtedly been widely embraced as a “game changer” across industries, skeptics are quick to point out AI’s limits within biopharma and healthcare. However, a closer
Bridging AI & Human Insights in Biopharma Markets Read More »
The hope for many companies developing drugs for rare diseases is this: the significant unmet need, given a dearth of treatment options, will drive demand and thus product uptake. Unfortunately,
Finding Patients With Rare Diseases: Two Truths And A Lie Read More »
I once thought I had multiple sclerosis (MS). Actually, I may still have multiple sclerosis. I really don’t know for sure. A few months ago, a series of MS disease-awareness
The Role of AI in Helping Clinicians Diagnose Patients Read More »
Nurse Practitioners (NPs) and Physician Assistants (PAs) are increasingly central to healthcare delivery, bridging gaps in access, especially in underserved areas. Their growing responsibilities, including diagnosing, managing patient care, and
The Twin High-Leverage Points of Identification and Activation To successfully address unmet medical needs in rare disease, we must first identify health care providers (HCPs) with a high likelihood of
Leverage AI for Precision in Rare Disease Diagnosis Read More »
CASE BACKGROUND Situation Client is focused on the discovery and development of precision medicines for difficult-to-treat cancers The target disease is rare. About 8,000 people in the United
Optimizing Trial Recruitment: Segmenting HCP Targeting Read More »
The pharmaceutical industry has been reshaped by many changes over the past decade, including the emergent power of managed care, the declining use of sales representatives, and the explosive growth
Thought Leader Engagement in Pharma’s Evolving Landscape Read More »
